Document Detail


Update on emerging technologies in breast imaging.
MedLine Citation:
PMID:  23138164     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Despite mammography's proven efficacy, there continues to be interest in newer technologies in breast cancer detection and expanded use of established technologies, especially in women with dense breast tissue and those at high risk. This article reflects on the development in the last ten years of some of these modalities and their current use.
Authors:
Stephanie K Patterson; Mitra Noroozian
Related Documents :
10602134 - Fluorescence staining of laryngeal neoplasms after topical application of 5-aminolevuli...
24426614 - Giant male fibroadenoma: a rare benign lesion.
23276914 - Integrating leptin and camp signalling pathways in triple-negative breast cancer cells.
24018804 - The analysis of microsatellite instability in extracolonic gastrointestinal malignancy.
20608934 - Bone morphogenetic protein-10 (bmp-10) inhibits aggressiveness of breast cancer cells a...
8776824 - Erythropoietin-producing adrenocortical carcinoma.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of the National Comprehensive Cancer Network : JNCCN     Volume:  10     ISSN:  1540-1413     ISO Abbreviation:  J Natl Compr Canc Netw     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-09     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101162515     Medline TA:  J Natl Compr Canc Netw     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1355-62     Citation Subset:  IM    
Affiliation:
From the University of Michigan Hospital and Health Systems, Ann Arbor, Michigan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Ovarian Cancer, Version 3.2012.
Next Document:  Point: Treating Stage II Colon Cancer: The Quest for Personalized Adjuvant Care.